Financial Performance - The company's operating revenue for Q1 2023 was ¥31,055,189.83, representing a decrease of 30.31% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥15,273,417.11, a decline of 595.36% year-over-year[5]. - The gross profit for Q1 2023 was CNY 16.66 million, an increase of 19.45% compared to CNY 13.95 million in the same period last year[14]. - The basic earnings per share were -¥0.18, a decrease of 460.00% year-over-year[6]. - Net loss for Q1 2023 was ¥15,273,425.53, compared to a net profit of ¥3,083,310.85 in Q1 2022, representing a significant decline[27]. Cash Flow - The net cash flow from operating activities was -¥32,069,367.61, indicating a significant cash outflow[6]. - The company reported a net cash flow from operating activities of CNY -32.07 million, compared to CNY -13.10 million in the same period last year[14]. - The cash inflow from operating activities was $77,034,599.19, a decrease of 47% compared to $145,214,785.15 in Q1 2022[30]. - The net cash outflow from operating activities was -$32,069,367.61, worsening from -$13,099,147.08 in the same period last year[30]. - The company reported a significant decrease in cash received from the sale of goods and services, totaling $67,483,438.18 in Q1 2023, down from $142,202,669.91 in Q1 2022[30]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,669,507,066.15, down 6.42% from the end of the previous year[6]. - As of March 31, 2023, the company’s total current assets were CNY 1.48 billion, down from CNY 1.60 billion at the end of 2022[22]. - Total liabilities decreased to ¥227,087,503.41 in Q1 2023 from ¥304,781,120.18 in Q4 2022, indicating a reduction in financial obligations[24]. - Non-current assets totaled ¥184,764,205.93 as of the end of Q1 2023, slightly down from ¥185,548,400.74 at the end of Q4 2022[24]. Research and Development - Research and development expenses totaled ¥5,579,534.54, an increase of 55.63% compared to the previous year, accounting for 17.97% of operating revenue, up 9.92 percentage points[6]. - The company reported a significant increase in research and development expenses, which rose to ¥5,579,534.54 in Q1 2023 from ¥3,585,079.75 in Q1 2022, reflecting a focus on innovation[26]. - The company is actively advancing the technical research and development of its biomass renewable energy subsidiary, with the first complete set of equipment currently in debugging[18]. Shareholder Information - The company reported a total of 4,068 common shareholders at the end of the reporting period[10]. - The top shareholder, Hu Mingming, holds 32,200,000 shares, representing 38.70% of the total shares[11]. Strategic Initiatives - The company plans to continue increasing investment in new technologies and product development[8]. - The company launched the first "Lake Chief Health Management Station" in the country, aimed at enhancing ecological environment governance and utilizing digital twin technology for real-time monitoring[17]. - The company established a joint venture with Zhejiang Nankong Group to enhance its competitive advantage in the ecological environment sector[19]. - The company’s blue-green algae governance maintenance revenue significantly increased compared to the same period last year, contributing to stable order backlog[13]. Tax and Deferred Assets - Deferred tax assets increased to ¥29,491,835.15 in Q1 2023 from ¥25,928,116.89 in Q4 2022, suggesting potential future tax benefits[24].
德林海(688069) - 2023 Q1 - 季度财报